Skip to main content

Abstract

Susac syndrome is a microangiopathy causing small infarcts in the brain, cochlea, and retina. It is characterized by the clinical triad of acute or subacute encephalopathy, sensorineural hearing loss, and retinal branch artery occlusions. This syndrome is probably an immune-mediated endotheliopathy that affects the microvasculature of the brain, retina, and inner ear, but it has also been postulated that Susac syndrome can be due to a thrombotic occlusion of the small vessels of these organs.

The diagnosis is made by the presence of the triad of acute or subacute encephalopathy, sensorineural hearing loss, and retinal branch artery occlusions. When this triad is not completed, the imaging techniques can help with the diagnosis.

The treatment includes immunosuppression (with high-dose steroids and cytotoxic drugs) and anticoagulation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aubert-Cohen F, Klein I, Alexandra JF, Bodaghi B, Doan S, Fardeay CM, Lavallée P, Peitte JC, Le Hoang P, Papo T.Long-term outcome in Susac syndrome. Medicine 2007; 86: 93–102.

    Article  Google Scholar 

  2. Susac JO, Hardman JM, Selhorst JB. Microangiopathy of the brain and retina. Neurology 1979; 29: 313–6.

    CAS  PubMed  Google Scholar 

  3. Magro CM. Susac syndrome – an autoimmune endotheliopathy. 1st Susac Symposium. Ohio State University, Columbus OH, April 2005.

    Google Scholar 

  4. Waldman J, Knight D. Antiendothelial cell antibodies in Susac’s syndrome. 1st Susac Symposium. Ohio State University, Columbus OH, April 2005.

    Google Scholar 

  5. Bucciarelli S, Cervera R, Martinez M, Latorre X, Font J. Susac’s syndrome or catastrophic antiphospholipid syndrome. Lupus 2004; 13: 607–8.

    Article  CAS  PubMed  Google Scholar 

  6. Susac JO. Susac syndrome: The triad of microangiopathy of the brain and retina with hearing loss in young men. Neurology 1994; 44: 591–3.

    CAS  PubMed  Google Scholar 

  7. O’Halloran HS, Pearson PA, Lee WB, Susac JO, Berger JR. Microangiopathy of the brain, retina, and cochlea (Susac syndrome). A report of five cases and a review of the literature. Ophtalmology 1998; 105: 1038–44.

    Article  Google Scholar 

  8. Papo T, Biousse V, Le Hoang P, Fardeu C, N’Guyen N, Houn DL, Aumaitre O, Bousser MG, Godeau P, Piette JC. Susac syndrome. Medicine (Baltimore) 1998; 77: 3–11.

    Article  CAS  Google Scholar 

  9. Petty GW, Engel AG, Younge BR, Duffy J, Yanagihara T, Lucchineti CF, Bartleson JD, Parisi JE, Kasperbauer JL, Rodriguez M. Retinocochleocerebral vasculopathy. Medicine (Baltimore) 1998; 77: 12–40.

    Article  CAS  Google Scholar 

  10. Egan RA, Ha Nguyen T, Gass JD, Rizzo JF III, Tivman J, Susac JO.Retinal arterial wall plaques in Susac syndrome. Am J Ophthalmol 2003; 135: 483–6.

    Article  PubMed  Google Scholar 

  11. Susac JO, Murtagh FR, Egan RA, Berger JR, Bakshi R, Lincoff N, Gean AD, Galetta SL, Fox RJ, Costello FE, Lee AG, Clark J, Layzer RB, Daroff RB.MRI findings in Susac's syndrome. Neurology 2003; 61: 1783–1787.

    CAS  PubMed  Google Scholar 

  12. White ML, Zhang Y, Smoker WR.Evolution of lesions in Susac syndrome at serial MR imaging with diffusion-weighted imaging and apparent diffusion coefficient values. Am J Neuroradiol 2004; 25: 706–13.

    PubMed  Google Scholar 

  13. Susac JO, Egan RA, Rennebohm RM, Lubow M. Susac’s syndrome: 1975–2005 microangiopathy/autoimmune endotheliopathy. J Neurol Sci 2007; 257: 270–2.

    Article  PubMed  Google Scholar 

  14. Gross M, Eliashar R.Update on Susac’s syndrome. Curr Opin Neurol 2005; 18: 311–4.

    Article  PubMed  Google Scholar 

  15. Lansberg MG, Thies VN, O’Brien MW, Ali JO, de Crespigny AJ, Tong DC, Moseley ME, Albers GW. Evolution of apparent diffusion coefficient, diffusion-weighted and T2-weighted signal intensity of acute stroke. Am J Neuroradiol 2001; 22: 537–44.

    Google Scholar 

  16. Xu MS, Tan CB, Umapathi T, Lim CC. Susac syndrome: Serial diffusion-weighted MR imaging. Magn Reson Imaging 2004; 22: 1295–8.

    Article  PubMed  Google Scholar 

  17. Recchia FM, Brown GC. Systemic disorders associated with retinal vascular occlusion. Curr Opin Ophthalmol 2000; 11: 462–7.

    Article  CAS  PubMed  Google Scholar 

  18. Susac JO.Susac’s syndrome. Am J Neuroradiol 2004; 25: 351–2.

    PubMed  Google Scholar 

  19. Rennebohm RM, Susac JO.Treatment of Susac’s syndrome. J Neurol Sci 2007; 257: 215–20.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Ugarte, M.F., Cervera, R. (2008). Susac Syndrome. In: Shoenfeld, Y., Cervera, R., Gershwin, M.E. (eds) Diagnostic Criteria in Autoimmune Diseases. Humana Press. https://doi.org/10.1007/978-1-60327-285-8_22

Download citation

Publish with us

Policies and ethics